US Proton Therapy Market Revenues to Increase at 16% CAGR through 2022, Projects RNCOS in Its New Report Recently Added at MarketPublishers.com
20 Oct 2016 • by Natalie Aster
LONDON – A wide range of technologically advanced therapies are introduced in the US, spurred primarily by the increase in cancer incidence. Proton therapy is one of them.
Formerly, the access to proton therapy in the US was limited for a vast population given a low number of proton centers in the country coupled with high barriers to insurance coverage for such procedures. However, the situation has changed; now many research institutions make substantial investments in proton therapy development to make it more accessible for local patients. Moreover, the insurance coverage for proton therapy in the US has also been improved: it is now covered by Medicare as well as almost all healthcare insurance providers in the country.
By 2022, the number of proton therapy centers is expected to reach 38. Up till 2022, the US proton therapy market is poised to keep to a growth trend. The country’s proton therapy market revenues will likely touch USD 1 billion by 2022, enjoying a 16% CAGR in the next 5 years.
New report “US Proton Therapy Market Forecast to 2022” by RNCOS E-Services presents a detailed analysis of the historical, current and forecast performance of the US proton therapy market.
The publications uncovers info on the existing proton centers in the country, examines the key market growth drivers and hinders, pinpoints top challenges and opportunities, investigates prevailing market development trends and sheds light on factors shaping the US proton therapy market. The study gives insights into the competitive landscape, offers details on major service providers and also equipment vendors, highlights planned proton therapy installations and centers in the country up to 2022. Furthermore, the report contains forecasts through 2022 and a valuable opportunity analysis for new market entrants.
Other insightful research reports by RNCOS are available in this Market Publishers’ catalogue.